Oxcarbazepine (Trileptal, Oxtellar XR)

FDA Approved 2000

Reviewed by the HeyPsych Medical Review Board

Board-certified psychiatrists and mental health professionals

Published January 20, 2026•Updated January 27, 2026•Reviewed January 27, 2026

Clinical summary for Oxcarbazepine (Trileptal, Oxtellar XR): Oxcarbazepine is a seizure medication that’s sometimes used off-label for bipolar disorder when other options have failed. It may reduce manic agitation, but it can also cause dizziness/sleepiness and—more importantly—dangerous low sodium. Rarely, it can cause severe allergic skin reactions. It also interacts with other meds, including hormonal birth control.

What It's Used For

Oxcarbazepine is primarily an antiseizure medication, but in psychiatry it sometimes shows up as an off-label, late-line option for bipolar disorder—especially when mania or mixed agitation keeps breaking through and you’ve already had solid trials of the usual first-line meds.

Primary Indications

Bipolar disorder (off-label): Alternative option for acute mania or mixed episodes and sometimes maintenance, usually after preferred treatments have been tried

Off-Label Uses

Not applicable for this medication.

What People Feel

Everyone responds differently, but these are the patterns I hear most often when oxcarbazepine is used for mood symptoms:

Calmer “edge” / less revved up

"I didn’t feel sedated—I just felt less keyed up."

How Fast It Works

Oxcarbazepine isn’t an “instant relief” med for anxiety or agitation. If it helps mood stability, it usually happens gradually as the dose is titrated to a therapeutic range.

Days 1-7

Side effects (dizziness, drowsiness, fog) can show up early—often before any mood benefit

1-3 weeks

Some people start noticing fewer spikes of agitation/activation as dosing becomes steadier

Ongoing

Hyponatremia risk is highest early (often within the first 3 months), but it can occur later too—so monitoring matters

Immediate-release

Usually split into 2 (sometimes 3) daily doses

Extended-release

Once daily, taken on an empty stomach; not interchangeable mg-for-mg with immediate-release

How Well It Works

Bipolar mania/mixed symptom improvement

Variable

vs First-line options have stronger evidence

Oxcarbazepine is not considered a first-line bipolar medication. In practice, it’s typically reserved for situations where multiple preferred agents have already been tried (alone and in combination). When it works, the benefit is usually a reduction in manic activation and irritability—not a clean, dramatic “switch off.”

Critical Safety Information

Low sodium (hyponatremia) and severe rash reactions are the two biggest safety issues to take seriously.

→If you develop a new rash, mouth sores, fever, facial swelling, or a feeling like you’re getting sick fast—stop and seek urgent medical care. Don’t “wait it out.”
→Ask your clinician when your sodium will be checked. If you feel unusually tired, confused, nauseated, headachy, or faint—get labs checked sooner.
→This med can make you dizzy or sleepy. Be careful driving or doing anything risky until you know how you respond.
→Tell your prescriber about every medication and supplement you take—oxcarbazepine has real interactions.
→If you use hormonal birth control: oxcarbazepine can reduce effectiveness. You may need a barrier method or a different contraceptive plan.
→Don’t stop suddenly after you’ve been on it for a while. Tapering is part of using this safely.

Side Effects

Most common: dizziness, drowsiness, fatigue, nausea, blurred/double vision, and coordination problems. The most clinically important lab issue is hyponatremia (low sodium).

Common Things People Notice

Dizziness or lightheadedness
Sleepiness or fatigue
Brain fog / slowed thinking
Nausea or vomiting
Double vision or blurry vision
Unsteady walking / poor coordination
Low sodium (can feel like fatigue, headache, confusion—or nothing until labs show it)

Common Side Effects

20% to 41%

Dizziness— This is one of the top reasons people stop. It often shows up during titration and may improve if dose increases are slower or dosing is adjusted.

12% to 14% (ER); 19% to 31% (IR)

Drowsiness / Somnolence— Can feel like sedation, low energy, or grogginess. If it’s tolerable, it sometimes improves over time. If it’s not, it’s a sign the dose may be climbing too fast.

3% to 6% (ER); 12% to 21% (IR)

Fatigue— Fatigue can be medication side effect, but it can also be a clue your sodium is dropping—especially if it’s new or worsening.

1% to 3% (ER); 2% to 17% (IR)

Ataxia / Coordination problems— Feeling off balance, clumsy, or unsteady. This matters more in older adults because falls become a real risk.

Diplopia: 10% to 13% (ER); 12% to 30% (IR)

Diplopia (double vision) / Visual disturbance— Often dose-related and more noticeable at peak levels. If you get sudden visual changes, don’t just push through—tell your prescriber.

Reported range varies widely; clinically important cases often occur early (first 3 months), but can occur later

Hyponatremia (low sodium)— Sometimes totally silent. Sometimes it looks like headache, nausea, confusion, lethargy, or worsening neurologic symptoms. This is why sodium monitoring isn’t optional if you’re taking this long-term.

⚠️ Serious Side Effects

Severe cutaneous adverse reactions (SJS/TEN) and DRESS: may include rash, blisters, mucosal sores, fever, facial swelling, swollen lymph nodes, and organ involvement. MEDICAL EMERGENCY.
Severe symptomatic hyponatremia: confusion, seizures, impaired consciousness, coma. MEDICAL EMERGENCY.
Blood dyscrasias: leukopenia, thrombocytopenia, rare agranulocytosis/aplastic anemia/pancytopenia. Seek evaluation for recurrent infections, unusual bruising, bleeding, or severe fatigue.
Psychiatric reactions have been reported (including mania-like behavior or psychosis). If mood becomes more activated, paranoid, or unsafe, contact your clinician urgently.
Suicidal ideation or behavioral changes: monitor closely, especially early in treatment.

Critical Drug Interactions

Oxcarbazepine can interact with many medications. The two psychiatry-relevant issues are (1) additive CNS sedation with other sedating agents and (2) reduced effectiveness of hormonal contraceptives.

With: Hormonal contraceptives (combined or progestin-based)

Risk: Reduced contraceptive hormone levels and possible contraceptive failure (unintended pregnancy).

Action: Use a barrier method in addition to hormonal contraception, or switch to a contraceptive plan less affected by enzyme induction. Discuss options before starting.

With: Other CNS depressants (alcohol, benzodiazepines, sedating antihistamines, sleep meds, opioids)

Risk: Additive dizziness, sedation, impaired coordination, and cognitive slowing; higher fall and accident risk.

Action: Use caution, avoid stacking sedatives when possible, and adjust dosing based on functioning and safety.

With: Medications that lower sodium (eg, diuretics and other agents associated with hyponatremia)

Risk: Higher risk of hyponatremia and symptoms from low sodium.

Action: Plan more frequent sodium monitoring and consider alternatives when feasible.

With: Concomitant antiseizure medications and other interacting drugs

Risk: Significant drug interactions may require dose/frequency adjustment or avoidance; interactions can change efficacy and side effects.

Action: Clinicians should review a drug-interactions database before starting or changing doses, and monitor clinically during titration.

Safe Discontinuation

If oxcarbazepine needs to be stopped after chronic use, it’s usually tapered—not yanked—unless there’s an urgent safety reason (like a serious rash). In seizure treatment, abrupt discontinuation can increase seizure frequency. In bipolar use, abrupt stopping can still destabilize sleep, mood, and overall nervous-system balance.

Key Points

Chronic therapy is typically withdrawn gradually over 1 to 6 months, individualized to the situation.
Taper slower if you’ve been on a higher dose, have had withdrawal-type symptoms before, or you’re medically complex (eg, older adult, renal impairment).
If stopping due to rash, severe hyponatremia, DRESS, or other serious reaction, the taper may need to be faster—or the medication stopped—based on clinician judgment and safety.
During taper: monitor mood (mania/mixed symptoms), sleep, irritability, and overall functioning; adjust the plan if symptoms rebound.

Dosing Information

Adult Dosing

mania initial: 300 mg/day PO (immediate-release or extended-release)

mania titration: Increase by 300 mg/day every 2 to 3 days based on response and tolerability

mania max: 2,400 mg/day PO

ir dosing: Immediate-release: divide total daily dose into 2 (sometimes 3) doses per day

xr dosing: Extended-release: once daily on an empty stomach (at least 1 hour before or 2 hours after food); swallow whole (do not cut, crush, or chew)

renal: Severe renal impairment (CrCl <30 mL/min): Start at one-half the usual starting dose (300 mg/day) and increase slowly (eg, 300 to 450 mg/day at weekly intervals) to desired response. ESRD on dialysis: use immediate-release instead of extended-release.

hepatic: Mild to moderate impairment: No adjustment typically needed. Severe impairment: Immediate-release—use caution (not well studied). Extended-release—use is not recommended (not studied).

elderly: Extended-release: Start 300 mg or 450 mg once daily; increase by 300 to 450 mg/day at weekly intervals to response. Older adults have higher risk of hyponatremia and CNS side effects—titrate conservatively.

Simple Explanation

This isn’t an as-needed med. The goal is steady coverage, and the dose is usually increased step-by-step. Immediate-release is typically twice daily; the XR version is once daily but has specific empty-stomach instructions and is not interchangeable mg-for-mg with immediate-release.

Pregnancy, Breastfeeding, Special Groups

Oxcarbazepine has special considerations in pregnancy, breastfeeding, older adults, and kidney disease. In psychiatry, the key issues are reproductive planning (including birth control interactions), careful monitoring, and shared decision-making about risks vs benefits.

👶Pregnancy

Oxcarbazepine and its active metabolite (MHD) cross the placenta. In people taking it for epilepsy, registry data suggest the major congenital malformation risk with oxcarbazepine monotherapy may be lower than with some other antiseizure medications, but malformations have been reported (including craniofacial and cardiac). Pregnancy can increase clearance and lower drug levels (especially starting in the second trimester), which may require dose adjustments. If used for bipolar disorder during pregnancy, the decision should be individualized using shared decision-making, balancing relapse risk against medication risks, with preference for the lowest effective dose and avoiding polytherapy when possible.

🤱Breastfeeding

Oxcarbazepine and MHD appear in breast milk, and reported relative infant doses are generally low in limited data. Breastfeeding may be acceptable in some cases, but infants should be monitored for sedation, poor feeding, weight gain issues, abnormal labs (platelets, liver function), and developmental milestones. If an infant shows signs of toxicity, pediatric evaluation and consideration of infant serum levels may be warranted.

👧Children & Adolescents (Under 18)

Not applicable for this medication.

👴Older Adults (65+)

Use with caution in adults 65+ due to risk of SIADH/hyponatremia and CNS side effects (dizziness, ataxia, falls). Start low, titrate slowly, and monitor sodium closely during initiation and dose changes.

🔬Liver Impairment

Mild to moderate impairment: generally no adjustment needed. Severe impairment: Immediate-release—use caution (not studied). Extended-release—not recommended (not studied).

💧Kidney Impairment

Severe renal impairment (CrCl <30 mL/min): Start at half the usual starting dose and titrate slowly. In dialysis/ESRD: immediate-release preferred over extended-release.

Clinical Monitoring

Serum sodium: Check during initiation and dose changes, especially in the first 3 months; recheck during maintenance if risk factors are present (older age, high doses, other sodium-lowering meds) or if symptoms appear (fatigue, headache, confusion, nausea, seizures).
Mood and safety: Track manic activation, irritability, sleep, impulsivity, and suicidal thoughts—especially in the first 1 to 12 weeks and after dose changes.
CNS effects: Dizziness, sedation, cognitive slowing, balance problems, and falls risk (particularly in older adults and when combined with other sedatives).
Skin and hypersensitivity: Monitor closely for rash, fever, facial swelling, mouth sores, lymph node swelling, or systemic symptoms consistent with DRESS; stop and evaluate urgently if suspected.
CBC: Periodic monitoring is reasonable given reports of leukopenia, thrombocytopenia, and rare severe blood dyscrasias.
Thyroid function: Consider periodic thyroid function tests (particularly in pediatric populations; in adults based on clinical context).
Drug interactions review: Re-check interactions at every medication change, including contraceptives and other agents that can worsen hyponatremia or sedation.
Renal function: Monitor clinically in patients with known kidney disease; severe impairment requires lower starting dose and slower titration.

Available Formulations

Immediate-release tablets: 150 mg, 300 mg, 600 mg (generic; Trileptal brand also available; some strengths may be scored)
Immediate-release oral suspension: 300 mg/5 mL (brand and generic availability varies by country; some products contain excipients like propylene glycol or alcohol—check labeling)
Extended-release tablets (24-hour): 150 mg, 300 mg, 600 mg (Oxtellar XR and some generics)

Mechanism of Action

Oxcarbazepine works mainly through its active metabolite (MHD). It blocks voltage-sensitive sodium channels, which helps stabilize overactive neurons and reduces repetitive firing. It may also increase potassium conductance and modulate high-voltage activated calcium channels. In bipolar disorder, any mood benefit is thought to be related to these stabilizing effects on neural excitability, but the exact mood mechanism isn’t fully defined.

Place in Treatment Algorithm

In psychiatry, oxcarbazepine is not a go-to first-line bipolar medication. It’s better thought of as a late-line alternative—sometimes considered when standard mood stabilizers and antipsychotics have been tried adequately (alone and in combinations) and the patient still has recurrent mania/mixed agitation or can’t tolerate preferred options. The biggest practical limitations are hyponatremia risk, serious rash risk in susceptible patients, and meaningful drug interactions (including reduced effectiveness of hormonal contraception).

Frequently Asked Questions

Is oxcarbazepine a first-line medication for bipolar disorder?

No. In psychiatry, oxcarbazepine is usually a late-line, off-label option. It’s most often considered after someone has had adequate trials of preferred treatments (like lithium, valproate, and/or atypical antipsychotics) and still has mania/mixed agitation—or can’t tolerate those meds.

What bipolar symptoms might oxcarbazepine help?

When it helps, the target is usually manic activation—things like agitation, irritability, racing energy, and mixed features. It’s not typically used as an anxiety PRN medication, and it’s not a dedicated sleep medication.

How is oxcarbazepine usually dosed for bipolar disorder?

A common approach is starting around 300 mg/day and increasing by 300 mg every 2 to 3 days based on response and tolerability, up to a maximum of 2,400 mg/day. Immediate-release is usually divided into 2 to 3 daily doses; extended-release is taken once daily on an empty stomach and must be swallowed whole.

What’s the biggest lab risk with oxcarbazepine?

Low sodium (hyponatremia). It can be mild or severe, and it can be asymptomatic or cause fatigue, headache, nausea, confusion, or worse. Sodium monitoring is especially important in the first 3 months and in older adults or anyone taking other meds that can lower sodium.

Do I need genetic testing before starting oxcarbazepine?

If you’re at increased genetic risk—especially many people of Asian ancestry, including South Asian patients—screening for the HLA-B*1502 allele may be recommended because it’s associated with higher risk of severe skin reactions like Stevens-Johnson syndrome/toxic epidermal necrolysis. If someone tests positive and other options exist, many clinicians avoid starting it.

Can oxcarbazepine cause sedation or brain fog?

Yes. Drowsiness, dizziness, fatigue, slowed thinking, and coordination problems are common—especially during titration. If you feel too sedated or off balance, it may mean the dose is rising too fast or the dose is too high for you.

Does oxcarbazepine interact with birth control?

It can. Oxcarbazepine may reduce the effectiveness of hormonal contraceptives, which can lead to contraceptive failure. Many patients are advised to use a barrier method in addition to hormonal contraception or consider an alternative contraceptive plan.

What’s the difference between Trileptal and Oxtellar XR?

Trileptal is immediate-release and is usually taken twice daily (sometimes three times daily). Oxtellar XR is extended-release and is taken once daily on an empty stomach. They are not bioequivalent and not interchangeable mg-for-mg—switching between them may require dose adjustment.

Can I stop oxcarbazepine suddenly?

Usually, no. After chronic use, it’s typically tapered—often over weeks to months—unless there’s an urgent safety issue like a serious rash. Stopping abruptly can destabilize symptoms and (in people with epilepsy) can increase seizure risk.

When should I seek urgent care while taking oxcarbazepine?

Seek urgent care for a new rash (especially with blisters or mouth sores), fever, facial swelling, severe fatigue/confusion, fainting, or any signs that could suggest severe hyponatremia or a serious allergic reaction. If you feel unsafe, suicidal, or severely agitated, get help immediately.

This medication information is for educational purposes only and is not a substitute for professional medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Never take medication without a prescription from a licensed healthcare provider.

Interested in this treatment?

This information is for educational purposes. Always consult with a qualified healthcare provider before starting any new treatment.

Locate Psychiatrists

Oxcarbazepine (Trileptal, Oxtellar XR)

FDA Approved 2000

Reviewed by the HeyPsych Medical Review Board

Board-certified psychiatrists and mental health professionals

Published January 20, 2026•Updated January 27, 2026•Reviewed January 27, 2026